- Report
- October 2024
- 184 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 182 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- September 2024
- 200 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- April 2025
- 92 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 150 Pages
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- August 2024
- 138 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- May 2024
- 135 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- August 2022
- 117 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2024
- 186 Pages
Global
€4546EUR$4,995USD£3,897GBP
- Report
- October 2023
- 106 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 120 Pages
Global
From €3500EUR$4,120USD£3,106GBP

The Artificial Saliva market is a subset of the Immune Disorders Drugs market, focusing on the development of treatments for dry mouth and other related conditions. Artificial saliva is a synthetic substance designed to mimic the properties of natural saliva, and is used to treat dry mouth, a condition caused by a lack of saliva production. Artificial saliva is also used to treat other conditions such as xerostomia, dysphagia, and oral mucositis. It is available in various forms, including sprays, gels, and lozenges.
The Artificial Saliva market is driven by the increasing prevalence of dry mouth and other related conditions, as well as the growing demand for effective treatments. Additionally, the development of new technologies and the increasing availability of artificial saliva products are expected to drive the market growth.
Some companies in the Artificial Saliva market include Biotène, Oasis, and Salivart. Show Less Read more